Cargando…

Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus

INTRODUCTION: Accurate blood glucose measurements are important in persons with diabetes during normal daily activities (NDA), even more so during exercise. We aimed to investigate the performance of fluorescence sensor-based and glucose oxidase-based interstitial glucose measurement during (intensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fokkert, Marion, van Dijk, Peter R, Edens, Mireille A, Díez Hernández, Alberto, Slingerland, Robbert, Gans, Rijk, Delgado Álvarez, Elías, Bilo, Henk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418676/
https://www.ncbi.nlm.nih.gov/pubmed/32784247
http://dx.doi.org/10.1136/bmjdrc-2020-001193
_version_ 1783569736707080192
author Fokkert, Marion
van Dijk, Peter R
Edens, Mireille A
Díez Hernández, Alberto
Slingerland, Robbert
Gans, Rijk
Delgado Álvarez, Elías
Bilo, Henk
author_facet Fokkert, Marion
van Dijk, Peter R
Edens, Mireille A
Díez Hernández, Alberto
Slingerland, Robbert
Gans, Rijk
Delgado Álvarez, Elías
Bilo, Henk
author_sort Fokkert, Marion
collection PubMed
description INTRODUCTION: Accurate blood glucose measurements are important in persons with diabetes during normal daily activities (NDA), even more so during exercise. We aimed to investigate the performance of fluorescence sensor-based and glucose oxidase-based interstitial glucose measurement during (intensive) exercise and NDA. RESEARCH DESIGN AND METHODS: Prospective, observational study in 23 persons with type 1 diabetes when mountain biking for 6 days, followed by 6 days of NDA. Readings of the Eversense (fluorescence-based continuous glucose monitoring (CGM); subcutaneously implanted) and of the Free Style Libre (FSL; glucose oxidase-based flash glucose monitoring (FGM); transcutaneously placed) were compared with capillary glucose levels (Free Style Libre Precision NeoPro strip (FSLCstrip)). RESULTS: Mean average differences (MAD) and mean average relative differences (MARD) were significantly different when comparing exercise with NDA (reference FSLCstrip); Eversense MAD 25±19 vs 17±6 mg/dL (p<0.001); MARD 17±6 vs 13%±6% (p<0.01) and FSL MAD 32±17 vs 18±8 mg/dL (p<0.01); MARD 20±7 vs 12%±5% (p<0.001). When analyzing the data according to the Integrated Continuous Glucose Monitoring Approvals (class II–510(K) guidelines), the overall performance of interstitial glucose readings within 20% of the FSLCstrip during exercise compared with NDA was 69% vs 81% for the Eversense and 59% vs 83% for the FSL, respectively. Within 15% of the FSLCstrip was 59% vs 70% for the Eversense and 46% vs 71% for the FSL. CONCLUSIONS: During exercise, both fluorescence and glucose oxidase-based interstitial glucose measurements (using Eversense and FSL sensors) were less accurate compared with measurements during NDA. Even when acknowledging the beneficial effects of CGM or FGM, users should be aware of the risk of diminished accuracy of interstitial glucose readings during (intensive) exercise.
format Online
Article
Text
id pubmed-7418676
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74186762020-08-18 Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus Fokkert, Marion van Dijk, Peter R Edens, Mireille A Díez Hernández, Alberto Slingerland, Robbert Gans, Rijk Delgado Álvarez, Elías Bilo, Henk BMJ Open Diabetes Res Care Metabolism INTRODUCTION: Accurate blood glucose measurements are important in persons with diabetes during normal daily activities (NDA), even more so during exercise. We aimed to investigate the performance of fluorescence sensor-based and glucose oxidase-based interstitial glucose measurement during (intensive) exercise and NDA. RESEARCH DESIGN AND METHODS: Prospective, observational study in 23 persons with type 1 diabetes when mountain biking for 6 days, followed by 6 days of NDA. Readings of the Eversense (fluorescence-based continuous glucose monitoring (CGM); subcutaneously implanted) and of the Free Style Libre (FSL; glucose oxidase-based flash glucose monitoring (FGM); transcutaneously placed) were compared with capillary glucose levels (Free Style Libre Precision NeoPro strip (FSLCstrip)). RESULTS: Mean average differences (MAD) and mean average relative differences (MARD) were significantly different when comparing exercise with NDA (reference FSLCstrip); Eversense MAD 25±19 vs 17±6 mg/dL (p<0.001); MARD 17±6 vs 13%±6% (p<0.01) and FSL MAD 32±17 vs 18±8 mg/dL (p<0.01); MARD 20±7 vs 12%±5% (p<0.001). When analyzing the data according to the Integrated Continuous Glucose Monitoring Approvals (class II–510(K) guidelines), the overall performance of interstitial glucose readings within 20% of the FSLCstrip during exercise compared with NDA was 69% vs 81% for the Eversense and 59% vs 83% for the FSL, respectively. Within 15% of the FSLCstrip was 59% vs 70% for the Eversense and 46% vs 71% for the FSL. CONCLUSIONS: During exercise, both fluorescence and glucose oxidase-based interstitial glucose measurements (using Eversense and FSL sensors) were less accurate compared with measurements during NDA. Even when acknowledging the beneficial effects of CGM or FGM, users should be aware of the risk of diminished accuracy of interstitial glucose readings during (intensive) exercise. BMJ Publishing Group 2020-08-11 /pmc/articles/PMC7418676/ /pubmed/32784247 http://dx.doi.org/10.1136/bmjdrc-2020-001193 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Metabolism
Fokkert, Marion
van Dijk, Peter R
Edens, Mireille A
Díez Hernández, Alberto
Slingerland, Robbert
Gans, Rijk
Delgado Álvarez, Elías
Bilo, Henk
Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
title Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
title_full Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
title_fullStr Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
title_full_unstemmed Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
title_short Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
title_sort performance of the eversense versus the free style libre flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
topic Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418676/
https://www.ncbi.nlm.nih.gov/pubmed/32784247
http://dx.doi.org/10.1136/bmjdrc-2020-001193
work_keys_str_mv AT fokkertmarion performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus
AT vandijkpeterr performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus
AT edensmireillea performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus
AT diezhernandezalberto performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus
AT slingerlandrobbert performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus
AT gansrijk performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus
AT delgadoalvarezelias performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus
AT bilohenk performanceoftheeversenseversusthefreestylelibreflashglucosemonitorduringexerciseandnormaldailyactivitiesinsubjectswithtype1diabetesmellitus